Herman, Talia http://orcid.org/0000-0001-7237-7008
Shema-Shiratzky, S.
Arie, L.
Giladi, N.
Hausdorff, J. M.
Funding for this research was provided by:
The Michael J. Fox Foundation for Parkinson's Research
Article History
Received: 2 January 2018
Accepted: 8 February 2018
First Online: 15 February 2018
Compliance with ethical standards
:
: TH, LA, SS declare no financial or other conflicts of interest. Prof. Hausdorff reports Grants from Michael J Fox Foundation, during the conduct of the study. Prof. Giladi serves as a member of the Editorial Board for the Journal of Parkinson’s Disease. He serves as consultant to Teva- NeuroDerm, Biogen, Pharma2B, Denali, Abbvie, AccelMed, Monfort and UCB. He receives royalties from LTI and payment for lectures at Teva, UCB, Abviee, Bial and Movement Disorder Society. He received research support from the Michael J Fox Foundation, the National Parkinson Foundation, the European Union 7th Framework Program and the Israel Science Foundation as well as from Teva NNE program, Biogen, LTI, and Pfizer.